STN
Stantec Inc.
STN's fundamentals are strong: revenue grew 12% and its operating margin rose 2 points to 10%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
STN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Stable |
STN's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
STN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 24x | $75.87 | +1% |
| Current | 24x | $75.13 | — |
| Fair | 36x | $113 | +51% |
| Expensive | 40x | $125 | +67% |
Historical ranges are pointers, not guarantees.
STN's PE is 24x, but its earnings don't support one, so it isn't a reliable read right now.
STN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for STN, with profitability improving.
STN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.12 | +16% |
| Q1 2026 | $3.03 | +27% |
| Q4 2025 | $2.96 | +32% |
| Q3 2025 | $2.99 | +42% |
| Q2 2025 | $2.69 | +26% |
| Q1 2025 | $2.38 | +9.7% |
| Q4 2024 | $2.25 | +7.1% |
| Q3 2024 | $2.11 | +0.5% |
STN's earnings per share have climbed steadily: $3.12 over the past year, up 16% from the year before, and higher year over year for 15 quarters in a row.
STN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.3B | +23% |
| Q1 2026 | $1.5B | +7.8% |
| Q4 2025 | $1.5B | +7.9% |
| Q3 2025 | $1.5B | +11% |
| Q2 2025 | $1B | -24% |
| Q1 2025 | $1.4B | +12% |
| Q4 2024 | $1.4B | +22% |
| Q3 2024 | $1.4B | +55% |
STN's revenue has grown year over year for four quarters in a row: $1.3B last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +5 points |
| Q1 2026 | 8.4% | +0.5 points |
| Q4 2025 | 8.7% | +1.1 points |
| Q3 2025 | 10% | +1.5 points |
| Q2 2025 | 9.4% | +1.3 points |
| Q1 2025 | 8% | +1.1 points |
| Q4 2024 | 7.6% | +0.3 points |
| Q3 2024 | 8.8% | -1.4 points |
STN's operating margin was 14% last quarter, up 5 points from the same quarter a year ago, near the top of its range since 2019.
STN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $69.3M | -14% |
| Q1 2026 | -$16.8M | -128% |
| Q4 2025 | $203.6M | -4.7% |
| Q3 2025 | $212M | +110% |
| Q2 2025 | $80.8M | +234% |
| Q1 2025 | $59.5M | +281% |
| Q4 2024 | $213.5M | +25% |
| Q3 2024 | $101.1M | +27% |
STN generated $468M in free cash flow over the past year, up 2.9% from the year before.
STN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -507K shares |
| 1 year | -0.4% | -507K shares |
| 3 years | +2.3% | +2.5M shares |
| 5 years | +1.6% | +1.8M shares |
| Available history | +1.8% | +2M shares |
STN has 114M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $123.7M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
STN spent $124M buying back its own shares over the past year, after none the year before.
STN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.0x | Moderate |
| Q1 2026 | 2.1x | Moderate |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 2.0x | Moderate |
| Q3 2024 | 2.4x | Moderate |
STN's net debt is about 2.0 years of its operating earnings (EBITDA), about the same as a year ago.
STN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.7 | Neutral |
| Stochastic | 62.9 | Neutral |
STN's weekly RSI is 52 (neutral) and its Stochastic is 63 (neutral).
STN PE vs Industrials Sector
| Metric | STN | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 0.2% above |
| PE % | 15 | 58 | 43 pts below |
STN is trading at 24x earnings, in line with the Industrials sector's median of 24x, though its earnings don't support one.
STN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $70.7 | 6.3% above |
| 20 week MA | $71.0 | 5.8% above |
| 50 week MA | $81.2 | 7.5% below |
| 100 week MA | $89.0 | 16% below |
| 200 week MA | $80.9 | 7.2% below |
STN has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 7.2% below its 200-week average.
STN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.1 | $32.2 | +14% |
| 2021 | $32.2 | $55.4 | +72% |
| 2022 | $55.4 | $47.1 | -15% |
| 2023 | $47.1 | $80.2 | +70% |
| 2024 | $80.2 | $78.9 | -1.6% |
| 2025 | $78.9 | $96.1 | +22% |
| 2026 YTD | $96.1 | $75.1 | -22% |
STN has finished higher in four of the last six years, two of them by more than 50%. It's down 22% so far in 2026.